載入...
4β‐hydroxycholesterol correlates with dose but not steady‐state concentration of carbamazepine: indication of intestinal CYP3A in biomarker formation?
AIM: 4β‐hydroxycholesterol (4βOHC) is an endogenous CYP3A(4) biomarker, which is elevated by use of the CYP3A4 inducer carbamazepine. Our aim was to compare to what extent serum concentration of 4βOHC correlates with dose (presystemic exposure) and steady‐state concentration (systemic exposure) of c...
Na minha lista:
| 發表在: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833147/ https://ncbi.nlm.nih.gov/pubmed/26574235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12833 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|